Ian MacLachlan
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Molecular Biology top 1%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA Interference and Gene Delivery 31
- Advanced biosensing and bioanalysis techniques 12
- RNA modifications and cancer 6
- Genetics 14
- Virus-based gene therapy research 10
- Co-authors
- Adam D. Judge (20 shared papers)Kevin McClintock (9 shared papers)Marjorie Robbins (11 shared papers)Lorne Palmer (7 shared papers)Vandana Sood (2 shared papers)James Heyes (4 shared papers)Dianne Fang (1 shared paper)Amy C. H. Lee (6 shared papers)
- Journals
- Cancer Research (5 papers)Molecular Therapy (5 papers)Human Gene Therapy (3 papers)Nature Biotechnology (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Ian MacLachlan
49 papers receiving 6.4k citations
Ian MacLachlan's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.4k
- Molecular Biology 5.5k
- Immunology 1.1k
- Infectious Diseases 776
- Biomaterials 528
Countries citing papers authored by Ian MacLachlan
This map shows the geographic impact of Ian MacLachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian MacLachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian MacLachlan more than expected).
Fields of papers citing papers by Ian MacLachlan
This network shows the impact of papers produced by Ian MacLachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian MacLachlan. The network helps show where Ian MacLachlan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian MacLachlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA Hit paper breakdown → | 2005 | 957 |
| 2 | Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Hit paper breakdown → | 2005 | 908 |
| 3 | 2005 | 469 | |
| 4 | 2005 | 437 | |
| 5 | 2010 | 342 | |
| 6 | 2009 | 329 | |
| 7 | 2009 | 273 | |
| 8 | 2005 | 257 | |
| 9 | 2007 | 257 | |
| 10 | 2005 | 225 | |
| 11 | 2008 | 217 | |
| 12 | 1999 | 207 | |
| 13 | 2015 | 190 | |
| 14 | 2006 | 181 | |
| 15 | 2008 | 172 | |
| 16 | 2005 | 171 | |
| 17 | 2006 | 100 | |
| 18 | 2014 | 77 | |
| 19 | 2007 | 71 | |
| 20 | Long-circulating vectors for the systemic delivery of genes. | 2001 | 70 |
About Ian MacLachlan
Ian MacLachlan is a scholar working on Molecular Biology, Genetics, Cancer Research, Immunology and Infectious Diseases, having authored 49 papers that have together received 6.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (31 papers), Advanced biosensing and bioanalysis techniques (12 papers), Virus-based gene therapy research (10 papers), Viral Infections and Outbreaks Research (7 papers), Hepatitis B Virus Studies (6 papers), RNA modifications and cancer (6 papers), Immunotherapy and Immune Responses (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (5.5k citations), Immunology (1.1k citations), Infectious Diseases (776 citations) and Biomaterials (528 citations). Ian MacLachlan has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Adam D. Judge, Kevin McClintock, Marjorie Robbins, Lorne Palmer, Vandana Sood, James Heyes, Dianne Fang, Amy C. H. Lee, Ellen Ambegia and K. Helen Bremner. Their work appears in journals such as Cancer Research, Molecular Therapy, Human Gene Therapy, Nature Biotechnology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.